IN VITRO EVIDENCES FOR SIMVASTATIN AND LOSARTAN POTASSIUM INTERACTION AND ITS IN VIVO IMPLICATIONS
In the present paper, we describe the in vitro availability of simvastatin, a potent HMG-CoA reductase inhibitor, in presence of losartan potassium, which is a non-peptide angiotensin II receptor antagonist. These studies were carried out at 37, 48 and 60°C in different pH environments simulating hu...
Guardado en:
Autores principales: | SAEED ARAYNE,M, SULTANA,NAJMA, HAROON,UROOJ, ZAIDI,BATOOL |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Química
2009
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072009000400024 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SIMULTANEOUS DETERMINATION OF ENALAPRIL AND STATIN'S IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2011) -
SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2010) -
Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers
por: Ahmed TA, et al.
Publicado: (2020) -
Managing blood pressure control in Asian patients: safety and efficacy of losartan
por: Cheung TT, et al.
Publicado: (2014) -
HPLC DETERMINATION OF EZETIMIBE AND SIMVASTATIN IN PHARMACEUTICAL FORMULATIONS
por: ASHFAQ,MUHAMMAD, et al.
Publicado: (2007)